Leptin-based intervention in systemic autoimmunity
Leptin-based intervention in systemic autoimmunity
批准号:
7038254
负责人:
ANTONIO LA CAVA
金额:
$22.63万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2008-03-31
关键词:
autoimmunitybiological signal transductioncellular pathologydisease /disorder modelenzyme linked immunosorbent assayfemalehelper T lymphocytehormone inhibitorhormone regulation /control mechanismimmunopharmacologyimmunotherapylaboratory mouseleptinlongitudinal animal studymolecular pathologynonhuman therapy evaluationpathologic processrecombinant proteinsserology /serodiagnosissystemic lupus erythematosus
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Leptin is a hormone primarily involved in the regulation of basal metabolism that also has an important role in immune responses. Leptin promotes inflammation and can accelerate onset and progression of several autoimmune diseases including systemic lupus erythematosus (SLE). Because of that, we will test whether leptin-based intervention may be beneficial for the course of SLE in a mouse model of SLE, the (NZB x NZW)F1 (NZB/W F1) mouse. Since we hypothesize that leptin affects the phenotype and function of some immune-cell subsets and intereferes/promotes the release of soluble mediators in order to exert its propathogenic effects in SLE, we will dissect several cellular and molecular events induced by leptin in NZB/W F1 mice. We will study the effects of leptin on autoreactive T cells and will characterize some intracellular signaling events induced by leptin. We will then test different approaches of leptin-based intervention in these mice to ultimately set the stage for translational studies to humans. By defining some crucial aspects related to the physiopathology of leptin in the development of systemic autoimmunity in NZB/W F1 mice, these studies will explore new strategies of therapeutic intervention in lupus mice for future translational research in humans aimed at improving management of this incurable disease.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Natural and adaptive immune cell-based therapies in autoimmunity.
自身免疫中基于自然和适应性免疫细胞的疗法。
DOI:
10.2174/092986706777442020
发表时间:
2006
期刊:
Current medicinal chemistry
影响因子:
4.1
作者:
[LaCava,Antonio, Shi,Fu-Dong]
通讯作者:
Shi,Fu-Dong
Autoimmunity and celiac disease.
自身免疫和乳糜泻。
DOI:
10.2174/138955708783498113
发表时间:
2008
期刊:
Mini reviews in medicinal chemistry
影响因子:
--
作者:
[Gianfrani,Carmen, Troncone,Riccardo, LaCava,Antonio]
通讯作者:
LaCava,Antonio
Autoantibody blockade in neonatal lupus
-
批准号:10170280
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2020
-
负责人:ANTONIO LA CAVA
-
依托单位:
Antibody-mediated suppression of autoimmunity in humanized mice
-
批准号:9895546
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2019
-
负责人:ANTONIO LA CAVA
-
依托单位:
Sexual Dimorphism and Dysregulated Immune Responses in SLE: The Role of Leptin
-
批准号:8178630
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2011
-
负责人:ANTONIO LA CAVA
-
依托单位:
Sexual Dimorphism and Dysregulated Immune Responses in SLE: The Role of Leptin
-
批准号:8321506
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2011
-
负责人:ANTONIO LA CAVA
-
依托单位:
Role of Leptin in Systemic Lupus Erythematosus
-
批准号:7146995
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2006
-
负责人:ANTONIO LA CAVA
-
依托单位:
Role of Leptin in Systemic Lupus Erythematosus
-
批准号:7648189
-
项目类别:
-
资助金额:$32.34万
-
财政年份:2006
-
负责人:ANTONIO LA CAVA
-
依托单位:
Role of Leptin in Systemic Lupus Erythematosus
-
批准号:7270077
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2006
-
负责人:ANTONIO LA CAVA
-
依托单位:
Role of Leptin in Systemic Lupus Erythematosus
-
批准号:7456425
-
项目类别:
-
资助金额:$32.34万
-
财政年份:2006
-
负责人:ANTONIO LA CAVA
-
依托单位:
Role of Leptin in Systemic Lupus Erythematosus
-
批准号:7876917
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2006
-
负责人:ANTONIO LA CAVA
-
依托单位:
Leptin-based intervention in systemic autoimmunity
-
批准号:6863804
-
项目类别:
-
资助金额:$19.28万
-
财政年份:2005
-
负责人:ANTONIO LA CAVA
-
依托单位:
海外基金